Another antibiotics company bites the dust: Nabriva
(Good news for superbugs. Bad news for humans. Further indictment of the "market.")
endpts.com
(Good news for superbugs. Bad news for humans. Further indictment of the "market.")
endpts.com
"An antibiotics biotech is about to throw in the towel, dealing another blow to a sparse R&D field and raising red flags in the light of antimicrobial resistance."
"Nabriva Therapeutics..is laying off nearly all its employees, returning the promotion and distribution rights of an antibacterial to Merck, canceling a loan agreement and making other moves to 'adequately fund an orderly wind down of the Companyβs operations.'"
"The board could seek liquidation and dissolution, Nabriva said."
Loading suggestions...